ANDA Litigation Settlements

Case Name Drug Patent No(s). Publicly Available Terms

Helsinn Healthcare SA v. Dr. Reddy’s Labs. Ltd., 11-3962 (D.N.J.)

Aloxi® (palonosetron hydrochloride for injection)



Dr. Reddy’s will be allowed to market generic Aloxi on Sept. 30, 2018, or earlier under undisclosed circumstances.

Remaining terms are confidential.

The articles on our Website include some of the publications and papers authored by our attorneys, both before and after they joined our firm. The content of these articles should not be taken as legal advice.